查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1407382

數位乳房 X 光檢查市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品、最終用戶區域和競爭細分

Digital Mammography Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By End-User Region and Competition
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年，全球數位乳房 X 光攝影市場價值為 11.2 億美元，預計在預測期內將強勁成長，到 2028 年複合CAGR為9.39%。全球數位乳房X 光攝影市場近年來經歷了顯著的成長和轉型，徹底改變了格局乳癌診斷。數位乳房X光檢查是一種最先進的影像技術，它取代了傳統的基於膠片的乳房X光檢查，提供卓越的影像品質、更高的診斷準確性和簡化的工作流程。該市場的擴張主要是由於全球乳癌盛行率的上升，以及人們意識的提高和早期檢測措施的推動。數位乳房X光檢查有助於檢測乳房異常，包括腫瘤和鈣化，具有更高的敏感性和特異性，從而改善結果並降低死亡率。

數位乳房X光攝影技術的進步在市場發展中發揮了關鍵作用。全視野數位乳房X光攝影（FFDM）和數位乳房斷層合成（DBT）等創新技術日益受到重視，它們提供的3D成像功能可以提供更全面、更詳細的乳房組織視圖。事實證明，這對於克服傳統2D乳房X光攝影的局限性特別有益，特別是在涉及緻密乳房組織的情況下。此外，人工智慧（AI）和機器學習演算法的整合透過協助放射科醫生解讀乳房X光影像、減少誤報並提高效率，進一步提高了診斷準確性。

全球數位乳房X光攝影市場的特點是競爭格局，主要參與者投資於研發活動，以引入尖端技術並獲得競爭優勢。從地理上看，由於數位乳房X光檢查系統的早期採用、強大的醫療基礎設施和乳癌的高盛行率，北美在市場上佔據主導地位。然而，由於醫療保健意識的提高、醫療保健基礎設施的改善和可支配收入的增加，亞太和拉丁美洲的新興經濟體對數位乳房X光檢查的需求不斷成長。

市場概況
預測期 2024-2028
2022 年市場規模 11.2億美元
2028 年市場規模 19億美元
2023-2028 年CAGR 9.39%
成長最快的細分市場 亞太地區
最大的市場 北美洲

主要市場促進因素

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：全球數位乳房 X 光攝影市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品（2D 全視野數位乳房 X 光斷層合成、3D 全視野數位乳房 X 光斷層合成）
    • 按最終使用者（醫院、門診手術中心、其他最終使用者）
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖
    • 按產品分類
    • 按最終用戶
    • 按地區

第 5 章：亞太地區數位乳房 X 光攝影市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國數位乳房X光攝影
    • 印度數位乳房X光攝影
    • 澳洲數位乳房X光攝影
    • 日本數位乳房X光攝影
    • 韓國數位乳房X光攝影

第 6 章：歐洲數位乳房 X 光攝影市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 西班牙
    • 義大利
    • 英國

第 7 章：北美數位乳房 X 光攝影市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第 8 章：南美洲數位乳房 X 光攝影市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 9 章：中東和非洲數位乳房 X 光攝影市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非數位乳房X光攝影
    • 沙烏地阿拉伯數位乳房X光攝影
    • 阿拉伯聯合大公國數位乳房X光攝影
    • 埃及數位乳房X光攝影

第 10 章：市場動態

  • 促進要素
  • 挑戰

第 11 章：市場趨勢與發展

  • 最近的發展
  • 產品發布
  • 併購

第 12 章：全球數位乳房 X 光攝影市場：SWOT 分析

第 13 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第14章：競爭格局

  • 豪洛捷公司
    • Company Snapshot
    • Products & Services
    • Current Capacity Analysis
    • Financials (In case of listed)
    • Recent Developments
    • SWOT Analysis
  • 通用電氣醫療集團
  • 皇家飛利浦公司
  • 西門子醫療股份有限公司
  • 富士軟片株式會社
  • 普蘭梅德公司
  • 東芝醫療系統
  • 金屬電子公司

第 15 章：策略建議

第 16 章：關於我們與免責聲明

簡介目錄
Product Code: 20249

Global Digital Mammography Market has valued at USD 1.12 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 9.39% through 2028. The Global Digital Mammography Market has experienced significant growth and transformation in recent years, revolutionizing the landscape of breast cancer diagnostics. Digital mammography, a state-of-the-art imaging technology, has replaced traditional film-based mammography, offering superior image quality, enhanced diagnostic accuracy, and streamlined workflow. The market's expansion is primarily driven by the rising prevalence of breast cancer worldwide, coupled with increasing awareness and early detection initiatives. Digital mammography facilitates the detection of breast abnormalities, including tumors and calcifications, with greater sensitivity and specificity, leading to improved outcomes and reduced mortality rates.

Technological advancements in digital mammography have played a pivotal role in market evolution. Innovations such as full-field digital mammography (FFDM) and digital breast tomosynthesis (DBT) have gained prominence, providing three-dimensional imaging capabilities that offer a more comprehensive and detailed view of breast tissue. This has proven particularly beneficial in overcoming the limitations of conventional two-dimensional mammography, especially in cases involving dense breast tissue. Moreover, the integration of artificial intelligence (AI) and machine learning algorithms has further augmented the diagnostic accuracy by assisting radiologists in the interpretation of mammographic images, reducing false positives and enhancing efficiency.

The global digital mammography market is characterized by a competitive landscape with key players investing in research and development activities to introduce cutting-edge technologies and gain a competitive edge. Geographically, North America has dominated the market, driven by the early adoption of digital mammography systems, robust healthcare infrastructure, and a high prevalence of breast cancer. However, emerging economies in Asia-Pacific and Latin America are witnessing a growing demand for digital mammography, attributed to increasing healthcare awareness, improving healthcare infrastructure, and rising disposable incomes.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 1.12 Billion
Market Size 2028USD 1.90 Billion
CAGR 2023-20289.39%
Fastest Growing SegmentAsia Pacific
Largest MarketNorth America

Key Market Drivers

Increasing Prevalence of Breast Cancer

The increasing prevalence of breast cancer has become a driving force behind the growth of the global digital mammography market. Breast cancer remains one of the most common cancers globally, affecting millions of women each year. As awareness campaigns and early detection initiatives gain momentum, the demand for advanced diagnostic technologies such as digital mammography is on the rise. Digital mammography offers several advantages over traditional film-based mammography, including improved image quality, faster image acquisition, and the ability to manipulate and store digital images efficiently. These advantages are crucial in the early detection of breast cancer, enabling healthcare professionals to identify abnormalities with greater precision.

The global digital mammography market is witnessing substantial expansion as healthcare providers increasingly recognize the importance of early detection in improving treatment outcomes and reducing mortality rates associated with breast cancer. Governments and healthcare organizations worldwide are investing in screening programs and infrastructure to facilitate widespread access to digital mammography services. The integration of artificial intelligence (AI) and machine learning algorithms in digital mammography systems further enhances diagnostic accuracy, aiding radiologists in the interpretation of complex images and reducing the likelihood of false positives or negatives.

Moreover, the rising prevalence of breast cancer is prompting technological advancements within the digital mammography market. Ongoing research and development efforts are focused on innovations such as 3D digital breast tomosynthesis, which provides a three-dimensional view of the breast, offering additional information for a more comprehensive assessment of breast abnormalities. These advancements contribute to the market's growth by addressing the limitations of traditional mammography and improving the overall diagnostic capabilities. As the global healthcare landscape continues to evolve, the digital mammography market is positioned to play a pivotal role in the fight against breast cancer. The increasing prevalence of breast cancer serves as a catalyst for technological innovation, creating a positive feedback loop where advancements in digital mammography contribute to more effective screening, early detection, and improved patient outcomes.

Technological Advancements in Digital Mammography

Technological advancements in digital mammography are serving as a driving force behind the robust growth of the Global Digital Mammography Market. Over the years, the field has witnessed transformative innovations, such as Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT), which have revolutionized breast imaging. FFDM provides high-resolution digital images, offering enhanced clarity and detail compared to traditional film-based mammography. This advancement not only facilitates more accurate detection of abnormalities but also streamlines the diagnostic process with faster image processing times. Digital Breast Tomosynthesis, or 3D mammography, has emerged as a breakthrough technology, addressing the limitations of 2D imaging, particularly in cases of dense breast tissue. By capturing multiple images from various angles, DBT provides three-dimensional views, enabling healthcare professionals to navigate through breast tissue layers, improving diagnostic accuracy.

Moreover, the integration of Artificial Intelligence (AI) and Machine Learning (ML) has further propelled the technological evolution of digital mammography. AI algorithms assist radiologists in analyzing mammographic images, offering a second layer of intelligent interpretation. These algorithms can identify subtle patterns and potential abnormalities, aiding in the early detection of breast cancer. The continuous refinement of these AI tools contributes to reducing false positives and negatives, ultimately enhancing diagnostic precision. The amalgamation of AI and digital mammography not only improves accuracy but also streamlines workflow, making the diagnostic process more efficient.

The ongoing research and development initiatives in the field of digital mammography continue to push the boundaries of technology, with a focus on improving image quality, reducing radiation exposure, and enhancing the overall patient experience. The incorporation of advanced features, such as computer-aided detection (CAD) systems, adds another layer of sophistication to digital mammography, allowing for a more comprehensive and nuanced analysis of breast images.

Growing Awareness and Early Detection Initiatives

The Global Digital Mammography Market is experiencing a significant upswing, propelled by the growing awareness of breast health and the implementation of early detection initiatives. Increasingly, governments, non-profit organizations, and healthcare institutions are championing breast cancer awareness campaigns, underscoring the importance of regular screenings and early diagnosis. This heightened awareness has resulted in a greater emphasis on advanced diagnostic technologies, with digital mammography emerging as a key player in this landscape. As women become more proactive about their health and well-being, the demand for efficient and accurate breast cancer screening methods has risen. Digital mammography, with its superior imaging capabilities and ability to detect abnormalities at early stages, aligns seamlessly with the objectives of these awareness campaigns.

Early detection initiatives, often accompanied by advocacy programs, encourage women to undergo routine screenings for breast cancer. The accessibility and efficiency of digital mammography make it a valuable tool in reaching these objectives. The technology's ability to provide high-resolution images, facilitate faster processing times, and offer three-dimensional views through techniques like Digital Breast Tomosynthesis (DBT) has positioned it as a preferred choice for early detection efforts. Moreover, the integration of Artificial Intelligence (AI) in digital mammography enhances diagnostic accuracy, reducing the likelihood of false positives and negatives.

The global shift towards proactive healthcare, coupled with the empowerment of individuals through awareness campaigns, has translated into a growing market for digital mammography. Healthcare providers and institutions are increasingly investing in these advanced technologies to meet the rising demand for early detection services. The synergy between awareness initiatives and the capabilities of digital mammography contributes not only to the diagnosis of breast cancer but also to a broader culture of preventative healthcare.

Key Market Challenges

High Initial Costs and Economic Constraints

The Global Digital Mammography Market, while experiencing significant growth, grapples with a formidable challenge - the high initial costs and economic constraints associated with adopting advanced digital mammography technologies. The deployment of state-of-the-art digital mammography systems requires a substantial upfront investment, posing a barrier to accessibility, particularly in resource-constrained healthcare settings.

The technology involves cutting-edge imaging systems, often accompanied by advanced software for image processing and analysis. While these innovations contribute to superior diagnostic accuracy and improved patient outcomes, they come at a considerable price. Healthcare institutions, especially those in developing regions, often face budgetary constraints that make it challenging to allocate funds for such high-cost investments.

Addressing this challenge requires a multifaceted approach. Collaboration between governments, healthcare institutions, and technology providers is crucial in developing innovative financial models and funding mechanisms. Public-private partnerships can play a pivotal role in facilitating the acquisition of digital mammography systems, ensuring that the financial burden is shared and that the benefits of advanced breast cancer detection technologies are extended to a broader spectrum of the population.

Furthermore, the industry must explore avenues for cost reduction without compromising the quality of care. Research and development efforts focused on developing more cost-effective digital mammography solutions can pave the way for affordable alternatives. This could involve innovations in manufacturing processes, materials, or even the integration of open-source technologies to reduce licensing and operational costs.

Radiation Exposure Concerns

Radiation exposure concerns stand as a significant obstacle in the path of the Global Digital Mammography Market. While digital mammography has proven instrumental in early breast cancer detection, anxieties regarding ionizing radiation persist among both healthcare professionals and patients, posing challenges to widespread acceptance and adoption.

Traditional mammography involves the use of ionizing radiation to create detailed images of breast tissue. While the radiation dose is generally considered low and safe, the cumulative effects of repeated exposure during routine screenings have prompted concerns. Patients, already grappling with the emotional burden of potential cancer diagnoses, are increasingly mindful of the long-term health implications associated with radiation exposure. This heightened awareness has led to a demand for alternative imaging technologies that offer diagnostic precision without compromising safety.

In response to these concerns, the industry has been actively exploring ways to minimize radiation exposure without sacrificing the diagnostic efficacy of digital mammography. Ongoing research and development efforts focus on developing low-dose imaging technologies, aiming to strike a delicate balance between obtaining high-quality diagnostic images and ensuring patient safety. Innovations in detector technology, image processing algorithms, and dose modulation techniques are continuously evolving to address radiation-related apprehensions.

Moreover, advocacy for adherence to dose optimization principles and guidelines has gained prominence within the medical community. Healthcare providers are encouraged to employ techniques that tailor radiation doses to individual patient characteristics, ensuring that the benefits of early breast cancer detection outweigh potential risks. Standardization of protocols and the establishment of guidelines for radiation dose management contribute to a more systematic and controlled approach to addressing radiation exposure concerns.

Key Market Trends

Rise of 3D Mammography (Digital Breast Tomosynthesis)

The rise of 3D mammography, also known as digital breast tomosynthesis (DBT), has emerged as a transformative force propelling the global digital mammography market to new heights. Digital breast tomosynthesis represents a significant advancement over traditional 2D mammography by providing a three-dimensional view of the breast tissue. This revolutionary technology allows radiologists to examine the breast in multiple thin slices, offering a more detailed and comprehensive assessment of abnormalities. As breast cancer detection and diagnosis become increasingly sophisticated, the demand for 3D mammography has surged, driven by its ability to improve the accuracy of breast cancer screenings.

One of the key factors contributing to the growth of the global digital mammography market is the enhanced diagnostic capabilities offered by 3D mammography. This technology reduces the limitations associated with overlapping breast tissue in traditional 2D mammography, leading to a reduction in false positives and false negatives. The improved accuracy translates to better-informed clinical decisions, ensuring that potential abnormalities are identified more precisely. As a result, 3D mammography is becoming the standard of care in breast cancer screening, further driving its adoption and contributing to the overall expansion of the digital mammography market.

Moreover, the rise of 3D mammography aligns with a broader trend of technological integration within the healthcare sector. The incorporation of artificial intelligence (AI) algorithms into 3D mammography systems enhances the interpretation of images, aiding radiologists in detecting subtle abnormalities and streamlining the diagnostic process. The synergy between 3D mammography and AI not only improves the efficiency of breast cancer screenings but also augments the capabilities of healthcare professionals in identifying and addressing potential issues at an earlier stage.

Integration of Artificial Intelligence (AI) and Machine Learning (ML)

The integration of Artificial Intelligence (AI) and Machine Learning (ML) is playing a pivotal role in boosting the global digital mammography market, revolutionizing the landscape of breast cancer detection and diagnosis. AI and ML algorithms have become indispensable tools in enhancing the capabilities of digital mammography systems, offering a sophisticated layer of intelligence to the interpretation of mammographic images. One of the key advantages is the ability of these technologies to analyze vast datasets quickly and accurately, assisting healthcare professionals in identifying subtle patterns and anomalies that may be indicative of breast cancer.

The utilization of AI and ML in digital mammography significantly contributes to improving diagnostic accuracy and efficiency. These technologies can assist radiologists in distinguishing between benign and malignant lesions, reducing the incidence of false positives and false negatives. By leveraging the power of machine learning, digital mammography systems can continuously learn and adapt, refining their diagnostic capabilities over time. This adaptive nature ensures that the technology remains at the forefront of breast cancer detection, constantly evolving to meet the demands of an ever-changing healthcare landscape.

Furthermore, AI and ML algorithms bring automation to the interpretation process, enabling faster and more standardized assessments of mammographic images. This not only enhances the speed of diagnosis but also promotes consistency across different healthcare settings. The ability of these technologies to handle complex data sets and identify subtle patterns that may escape the human eye empowers healthcare professionals with a valuable tool for early detection and intervention. The global digital mammography market is witnessing a surge in demand for AI and ML-integrated solutions as healthcare providers recognize the transformative impact on patient outcomes. Governments and institutions are increasingly investing in the implementation of these technologies to improve breast cancer screening programs and reduce the burden on healthcare systems.

Segmental Insights

Product Insights

Based on the Product, 3D Full Field Digital Mammography Tomosynthesis emerged as the dominant segment in the global market for Global Digital Mammography in 2022. The primary reason for the high demand for 3D DBT lies in its ability to address some limitations associated with traditional 2D FFDM. While 2D mammography provides valuable information for breast cancer screening, it may encounter challenges in cases involving dense breast tissue. Dense breasts can sometimes obscure abnormalities, leading to false negatives or inconclusive results.

End-User Insights

Based on the End-User, hospitals emerged as the dominant segment in the global market for Global Digital Mammography Market in 2022. Hospitals are key institutions that provide a wide range of healthcare services, including diagnostic imaging. Digital mammography is a critical tool for breast cancer screening and diagnosis, making it an integral part of the services offered by hospitals.Many hospitals have specialized breast health centers within their facilities. These centers focus specifically on breast imaging, screening, and diagnosis. Given the importance of mammography in breast cancer detection, hospitals with dedicated breast health centers are significant contributors to the demand for digital mammography systems.

Regional Insights

North America emerged as the dominant player in the Global Digital Mammography Market in 2022, holding the largest market share. North America, particularly the United States, is known for its early adoption of advanced healthcare technologies. The region often serves as an early adopter for cutting-edge medical imaging equipment, including digital mammography systems. The well-developed healthcare infrastructure in North America, including a network of hospitals, clinics, and imaging centers, supports the widespread adoption of digital mammography. Accessibility to advanced healthcare services contributes to the market's growth in the region.

Key Market Players

Hologic Inc

GE Healthcare

Koninklijke Philips NV

Siemens Healthcare GmBH

Fujifilm Corporation

Planmed Oy

Toshiba Medical Systems

Metaltronica S.p.A

Report Scope:

In this report, the Global Digital Mammography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Global Digital Mammography Market, By Product:

  • 2D Full Field Digital Mammography Tomosynthesis
  • 3D Full Field Digital Mammography Tomosynthesis

Global Digital Mammography Market, By End-User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-Users

Global Digital Mammography Market, By Application:

  • Clinical
  • System

Global Digital Mammography Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Digital Mammography Market.

Available Customizations:

  • Global Digital Mammography Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Digital Mammography Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Product (2D Full Field Digital Mammography Tomosynthesis, 3D Full Field Digital Mammography Tomosynthesis)
    • 4.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Other End-Users)
    • 4.2.3. By Region
    • 4.2.4. By Company (2022)
  • 4.3. Market Map
    • 4.3.1. By Product
    • 4.3.2. By End-User
    • 4.3.3. By Region

5. Asia Pacific Digital Mammography Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product
    • 5.2.2. By End-User
    • 5.2.3. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Digital Mammography Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Product
        • 5.3.1.2.2. By End-User
    • 5.3.2. India Digital Mammography Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Product
        • 5.3.2.2.2. By End-User
    • 5.3.3. Australia Digital Mammography Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Product
        • 5.3.3.2.2. By End-User
    • 5.3.4. Japan Digital Mammography Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Product
        • 5.3.4.2.2. By End-User
    • 5.3.5. South Korea Digital Mammography Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Product
        • 5.3.5.2.2. By End-User

6. Europe Digital Mammography Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End-User
    • 6.2.3. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Digital Mammography Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End-User
    • 6.3.2. Germany Digital Mammography Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End-User
    • 6.3.3. Spain Digital Mammography Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End-User
    • 6.3.4. Italy Digital Mammography Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product
        • 6.3.4.2.2. By End-User
    • 6.3.5. United Kingdom Digital Mammography Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product
        • 6.3.5.2.2. By End-User

7. North America Digital Mammography Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End-User
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Digital Mammography Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End-User
    • 7.3.2. Mexico Digital Mammography Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End-User
    • 7.3.3. Canada Digital Mammography Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End-User

8. South America Digital Mammography Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End-User
    • 8.2.3. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Digital Mammography Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End-User
    • 8.3.2. Argentina Digital Mammography Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End-User
    • 8.3.3. Colombia Digital Mammography Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End-User

9. Middle East and Africa Digital Mammography Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End-User
    • 9.2.3. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Digital Mammography Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End-User
    • 9.3.2. Saudi Arabia Digital Mammography Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End-User
    • 9.3.3. UAE Digital Mammography Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End-User
    • 9.3.4. Egypt Digital Mammography Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By End-User

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Digital Mammography Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Hologic Inc.
    • 14.1.1. Company Snapshot
    • 14.1.2. Products & Services
    • 14.1.3. Current Capacity Analysis
    • 14.1.4. Financials (In case of listed)
    • 14.1.5. Recent Developments
    • 14.1.6. SWOT Analysis
  • 14.2. GE Healthcare
  • 14.3. Koninklijke Philips NV
  • 14.4. Siemens Healthcare GmBH
  • 14.5. Fujifilm Corporation
  • 14.6. Planmed Oy
  • 14.7. Toshiba Medical Systems
  • 14.8. Metaltronica S.p.A

15. Strategic Recommendations

16. About Us & Disclaimer